Robert J. Schneider

Albert Sabin Professor of Molecular Pathogenesis at NYU School of Medicine, Alexandria Center for Life Sciences

I am the Albert Sabin Professor of Molecular Pathogenesis, Associate Dean for NYU Technology Ventures and Partnerships (the technology, commercialization and therapeutics discovery office of NYU), and Co-director of the Breast Cancer Research Program at NYU School of Medicine. Our research is directed to three major areas: (1) translational regulation of advanced breast cancers and the development of new treatment strategies and therapeutics for advanced cancers; (2) translational regulation of the immune response and applications in development of immune-oncology therapeutics; (3) and regulation of adult tissue stem cells and tissue regeneration controlled by targeted mRNA decay and translational regulation.